Editorial Policy

Originally Published: August 2, 2024
Effective Date: May 6, 2026
Last Updated: May 6, 2026

This Editorial Policy explains how content is researched, written, reviewed, updated, and corrected at teernight.live (the “Site”). We publish this policy publicly because trust is the most important thing we owe our readers, our advertisers, and the platforms (including Google AdSense and Google Ad Manager) on which our content appears. Mesothelioma and asbestos-related disease coverage is a YMYL (Your Money or Your Life) topic that affects health and finances; it requires extra care.

1. Mission and Audience

Our mission is to make information about mesothelioma, asbestos exposure, and related medical and legal options more accessible and accurate for the people who need it. Our primary audience includes patients newly diagnosed with mesothelioma or asbestosis, family caregivers, veterans (especially Navy and shipyard veterans), occupationally exposed workers, and the relatives of people who passed away before pursuing compensation. We also write for clinicians, advocates, students, and journalists looking for plain-language explainers.

2. What We Publish — and What We Do Not

We publish:

  • Explanatory articles on mesothelioma (pleural, peritoneal, pericardial, testicular), asbestos lung cancer, and asbestosis — symptoms, diagnosis, staging, treatment, and prognosis.
  • Practical guides for caregivers, including symptom management, finances, and end-of-life considerations.
  • Background on asbestos exposure pathways — occupational, environmental, military, and consumer products.
  • Plain-language coverage of asbestos trust funds, lawsuits, settlements, statutes of limitations, and VA benefits, written without legal advocacy.
  • Resource roundups (cancer centres, advocacy groups, federal agencies).

We do not publish:

  • Personalised medical, legal, or financial advice.
  • Endorsements or rankings of specific attorneys, law firms, hospitals, or treatment programs in exchange for payment.
  • Content that promotes unproven cures, “alternative” cancer therapies that lack credible evidence, or treatments that could delay evidence-based care.
  • Content that targets, demeans, or discriminates against any individual or group.
  • Content that violates Google’s Publisher Policies, Restricted Content rules, or Inventory and Site Quality requirements.
  • Content created solely to manipulate search rankings or ad systems.

3. Sourcing Standards

We rely first on primary, authoritative sources, including:

  • Medical: National Cancer Institute (NCI), National Institutes of Health (NIH), American Cancer Society (ACS), Centers for Disease Control and Prevention (CDC), peer-reviewed oncology and pulmonology literature indexed in PubMed, the National Comprehensive Cancer Network (NCCN) guidelines, the Mesothelioma Applied Research Foundation, and clinical-trial registries (ClinicalTrials.gov).
  • Exposure and regulation: Environmental Protection Agency (EPA), Occupational Safety and Health Administration (OSHA), Mine Safety and Health Administration (MSHA), Agency for Toxic Substances and Disease Registry (ATSDR), and state environmental agencies.
  • Veterans: Department of Veterans Affairs (VA) and VA Office of Inspector General publications, plus VA-accredited representatives where appropriate.
  • Legal: primary statutes (state and federal), published asbestos-trust governance documents (Trust Distribution Procedures, or “TDPs”), reported case law, the Manville Personal Injury Settlement Trust and other trust public reports, and the Government Accountability Office (GAO) on asbestos trusts.

Secondary sources (news organisations, academic institutions, large-scale studies) are used to provide context. We avoid sourcing from anonymous forums, low-quality content farms, attorney directories presented as journalism, or marketing material disguised as editorial.

4. Research, Writing, and Review Workflow

  1. Brief. An editor scopes the article, identifies the audience question it answers, and lists required sources.
  2. Draft. The writer (human or human-supervised) produces a draft, citing sources inline.
  3. Fact check. Every factual claim, statistic, regulation, dollar figure, and survival statistic is verified against a primary source.
  4. Edit. An editor reviews for accuracy, clarity, structure, tone, and policy compliance.
  5. Sensitivity review. Articles that touch on terminal illness, end-of-life care, hospice, suicide, or grief receive an additional review against safe-messaging guidelines.
  6. Legal/policy check. Articles that could implicate medical, legal, or advertising policy receive a final compliance pass — especially articles that mention specific compensation amounts, statutes of limitations, trust payouts, VA presumptive conditions, or specific attorneys/firms.
  7. Publish. The article is published with publication date, last-updated date, and editor attribution.

5. Use of AI-Assisted Tools

We may use AI-assisted tools for research, brainstorming, drafting, copyediting, summarisation, accessibility checks, and metadata generation. We treat AI output as a starting point, not a finished product. Every published article is reviewed and edited by a human for accuracy, sourcing, tone, and policy compliance. We do not publish unedited AI output. We do not fabricate quotes, statistics, citations, expert names, court decisions, or dollar amounts.

6. Author Attribution

Articles display the name of the editor responsible for the published version. Where contributors have specific credentials or expertise, we note those credentials honestly. We do not invent fictitious authors, fabricate biographies, or claim medical or legal credentials we do not have.

7. Updates and Corrections

We update articles when:

  • Treatment guidelines (NCCN, ASCO, ESMO, etc.) materially change.
  • Regulatory rules, trust-fund payout schedules, statutes of limitations, or VA presumptive conditions change.
  • New peer-reviewed studies materially change the consensus.
  • A reader, expert, or our own review identifies an inaccuracy.
  • Linked resources move or are deprecated.

Substantive updates are reflected in the article’s “Last Updated” date. Material corrections are noted at the bottom of the affected article with a brief description of what changed and when. Typo and formatting fixes do not require a correction note.

To request a correction or flag an issue, email support@teernight.live with the subject [Editorial] and a link to the article.

8. Editorial Independence

We maintain a strict separation between advertising and editorial. Advertisers, sponsors, affiliate partners, and any law firms or treatment centres that appear in articles or advertisements do not:

  • Commission articles.
  • Review articles before publication.
  • Approve or veto coverage of any topic, brand, attorney, firm, or competitor.
  • Influence which sources we cite or which conclusions we reach.

If an article references a specific attorney, law firm, treatment centre, or service that is also a current advertiser or affiliate partner, that relationship is disclosed clearly. See our Advertising Disclosure.

9. Sponsored Content and Native Advertising

If we ever publish sponsored, paid, or native content, it will be clearly and conspicuously labelled as such (for example, “Sponsored,” “Paid Partnership,” or “Advertisement”) in a way that is unambiguous to a typical reader and consistent with the FTC’s Endorsement Guides and Google’s publisher policies. Sponsored content is held to the same factual-accuracy standards as our editorial content. We do not publish sponsored content that promotes a specific attorney or law firm to readers in active legal jeopardy.

10. Conflicts of Interest

Editors and writers must disclose any personal, financial, or professional relationship that could create — or appear to create — a conflict with the subject of an article. Where such a conflict exists, the contributor either recuses from the assignment or the relationship is disclosed in the article.

11. Plagiarism and Originality

We do not plagiarise. Quotations are attributed. Paraphrased ideas are credited to the original source with a link wherever possible. We do not copy-paste material from other publishers, AI outputs, or any other source without proper attribution and rights.

12. Privacy of Sources and Subjects

Where articles include real-world examples, we either use composite or hypothetical scenarios or obtain informed consent for use of real details. We do not identify individuals as having a mesothelioma or asbestos-related diagnosis without their explicit, informed permission. We do not name minors in any health-related context.

13. Comments and Community

Where comments are enabled, they are moderated. We remove comments that violate our Terms of Service, including comments that are abusive, off-topic, contain personal medical or legal advice to other readers, share private health information, recruit clients for a law firm, promote unproven treatments, or are spammy. Persistent violators are blocked.

14. Coverage of Compensation Amounts

When articles discuss settlement amounts, jury verdicts, or trust-fund payouts, we identify the source of the figure (for example, a specific reported case, a published trust report, or an aggregate study) and note that past results are no guarantee of future outcomes. Settlement amounts depend heavily on the facts of each case, jurisdiction, and procedural posture. We do not promise readers any specific dollar outcome.

15. Compliance With Platform Policies

Our content is intended to comply with Google AdSense Program Policies, Google Publisher Policies, Google Publisher Restrictions, and the Inventory and Site Quality requirements applied to publishers using Google Ad Manager. Where Google’s policies prohibit or restrict ad serving on certain content, we either avoid that content or, if we do publish it for legitimate educational reasons, we may opt out of monetisation on that page.

16. Feedback

Reader feedback drives our update cycle. To suggest an article, point out a gap, share an experience, or correct a mistake, email support@teernight.live with the subject [Editorial].